Your browser doesn't support javascript.
loading
Molecular basis of ETV6-mediated predisposition to childhood acute lymphoblastic leukemia.
Nishii, Rina; Baskin-Doerfler, Rebekah; Yang, Wentao; Oak, Ninad; Zhao, Xujie; Yang, Wenjian; Hoshitsuki, Keito; Bloom, Mackenzie; Verbist, Katherine; Burns, Melissa; Li, Zhenhua; Lin, Ting-Nien; Qian, Maoxiang; Moriyama, Takaya; Gastier-Foster, Julie M; Rabin, Karen R; Raetz, Elizabeth; Mullighan, Charles; Pui, Ching-Hon; Yeoh, Allen Eng-Juh; Zhang, Jinghui; Metzger, Monika L; Klco, Jeffery M; Hunger, Stephen P; Newman, Scott; Wu, Gang; Loh, Mignon L; Nichols, Kim E; Yang, Jun J.
Afiliação
  • Nishii R; Department of Pharmaceutical Sciences and.
  • Baskin-Doerfler R; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Yang W; Department of Pharmaceutical Sciences and.
  • Oak N; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Zhao X; Department of Pharmaceutical Sciences and.
  • Yang W; Department of Pharmaceutical Sciences and.
  • Hoshitsuki K; Department of Pharmaceutical Sciences and.
  • Bloom M; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Verbist K; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Burns M; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA.
  • Li Z; Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
  • Lin TN; Department of Paediatrics, National University of Singapore, Singapore, Singapore.
  • Qian M; Department of Pharmaceutical Sciences and.
  • Moriyama T; Department of Pharmaceutical Sciences and.
  • Gastier-Foster JM; Children's Hospital of Fudan University, Shanghai, China.
  • Rabin KR; Institutes of Biomedical Sciences, Fudan University, Shanghai, China.
  • Raetz E; Department of Pharmaceutical Sciences and.
  • Mullighan C; Institute for Genomic Medicine, Nationwide Children's Hospital, Columbus, OH.
  • Pui CH; Department of Pathology and.
  • Yeoh AE; Department of Pediatrics, The Ohio State University, Columbus, OH.
  • Zhang J; Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX.
  • Metzger ML; Department of Pediatrics, NYU Langone Medical Center, New York, NY.
  • Klco JM; Department of Pathology and.
  • Hunger SP; Hematological Malignancies Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, TN.
  • Newman S; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN.
  • Wu G; Hematological Malignancies Program, Comprehensive Cancer Center, St. Jude Children's Research Hospital, Memphis, TN.
  • Loh ML; Khoo Teck Puat-National University Children's Medical Institute, National University Hospital, National University Health System, Singapore, Singapore.
  • Nichols KE; VIVA-NUS Center for Translational Research in Acute Leukaemia, Department of Paediatrics, Yong Loo Lin School of Medicine, Singapore, Singapore.
  • Yang JJ; Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore.
Blood ; 137(3): 364-373, 2021 01 21.
Article em En | MEDLINE | ID: mdl-32693409
ABSTRACT
There is growing evidence supporting an inherited basis for susceptibility to acute lymphoblastic leukemia (ALL) in children. In particular, we and others reported recurrent germline ETV6 variants linked to ALL risk, which collectively represent a novel leukemia predisposition syndrome. To understand the influence of ETV6 variation on ALL pathogenesis, we comprehensively characterized a cohort of 32 childhood leukemia cases arising from this rare syndrome. Of 34 nonsynonymous germline ETV6 variants in ALL, we identified 22 variants with impaired transcription repressor activity, loss of DNA binding, and altered nuclear localization. Missense variants retained dimerization with wild-type ETV6 with potentially dominant-negative effects. Whole-transcriptome and whole-genome sequencing of this cohort of leukemia cases revealed a profound influence of germline ETV6 variants on leukemia transcriptional landscape, with distinct ALL subsets invoking unique patterns of somatic cooperating mutations. 70% of ALL cases with damaging germline ETV6 variants exhibited hyperdiploid karyotype with characteristic recurrent mutations in NRAS, KRAS, and PTPN11. In contrast, the remaining 30% cases had a diploid leukemia genome and an exceedingly high frequency of somatic copy-number loss of PAX5 and ETV6, with a gene expression pattern that strikingly mirrored that of ALL with somatic ETV6-RUNX1 fusion. Two ETV6 germline variants gave rise to both acute myeloid leukemia and ALL, with lineage-specific genetic lesions in the leukemia genomes. ETV6 variants compromise its tumor suppressor activity in vitro with specific molecular targets identified by assay for transposase-accessible chromatin sequencing profiling. ETV6-mediated ALL predisposition exemplifies the intricate interactions between inherited and acquired genomic variations in leukemia pathogenesis.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Predisposição Genética para Doença / Proteínas Proto-Oncogênicas c-ets / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Predisposição Genética para Doença / Proteínas Proto-Oncogênicas c-ets / Leucemia-Linfoma Linfoblástico de Células Precursoras Tipo de estudo: Prognostic_studies Limite: Child / Humans Idioma: En Revista: Blood Ano de publicação: 2021 Tipo de documento: Article